Joseph Rubinfeld serves as Executive at Amarantus Bioscience Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Rubinfeld has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 8, 2014 involved receiving (via award) 116,500 shares valued at $10.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 8, 2014 | AMBS | $10.5K | Award | 116,500 | $0.09 | Discretionary |
Joseph Rubinfeld currently holds 2,056,500 shares of Amarantus Bioscience Holdings, Inc. (AMBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Rubinfeld has been a net neutral trader of AMBS stock. They have purchased $0 and sold $0 worth of shares.
Joseph Rubinfeld's most recent insider trade was on Dec 8, 2014, when they sold 116,500 shares at $0.09 per share.
Get notified when new Form 4 filings are submitted